Publication list

THE PURPOSE OF RESEARCH IS TO INCREASE OUR INSIGHT IN FUNCTION AND DYSFUNCTION OF THE VISUAL SYSTEM

  • B
  • C
  • D
  • F
  • L
  • M
  • R
  • S
  • V
  • W
  • - All
LAFAUT Bart
1.Lafaut B.A., Sallet G. and De Laey J.J. (1993). Hypofluorescence in infrared angiography. Bull. Soc. belge Ophtalmol. 250, 45-50
2.Lafaut B.A., Hanssens M., Verbraeken H. and De Laey J.J. (1994). Chorioretinal biopsy in the diagnosis of intraocular lymphoma: a case report. Bull. Soc. belge Ophtalmol. 252, 67-73
3.Lafaut B.A., Bourgoignie K.B., Sallet G. and De Laey J.J. (1994). Diffuse bilateral proliferation of uveal melanocytes. Apropos of an uncommon case (French) (review). J. Fr. Ophtalmol. 17 (3), 208-213
4.Lafaut B.A., Sallet G. and De Laey J.J. (1995). Discrepancy between indocyanine green and fluorescein angiography in occult choroidal neovascularisation. Bull. Soc. belge Ophtalmol. 255, 69-77
5.Lafaut B.A., Vianna R.N., De Baets F. and Meire F. (1995). Unilateral cytomegalovirus retinitis in a patient with immunoglobulin G2 deficiency. Ophthalmologica. 209 (1), 40-43
6.Lafaut B.A., van Egmond J. and De Laey J.J. (1995/1996). Asymmetric fundus flavimaculatus/Stargardt’s disease, associated with unilateral myopia. Int. Ophthalmol. 19 (4), 253-255
7.Amoaku W.M., Lafaut B., Sallet G. and De Laey J.J. (1995). Radiation choroidal vasculopathy: an indocyanine green angiography study. Eye. 9 (Pt. 6), 738-744
8.Sallet G., Amoaku W.M., Lafaut B.A., Brabant P. and De Laey J.J. (1995). Indocyanine green angiography of choroidal tumors. Graefes Arch. Clin. Exp. Ophthalmol. 233 (11), 677-689
9.Sallet G., Lafaut B.A. and De Laey J.J. (1996). Indocyanine green angiography and age-related serous pigment epithelial detachment. Graefes Arch. Clin. Exp. Ophthalmol. 234 (1), 25-33
10.Lafaut B.A., Priem H. and De Laey J.J. (1996). Premacular fibrosis in juvenile Coats’ disease with spontaneous peeling after photocoagulation of the congenital vascular anomalies. Bull. Soc. belge Ophtalmol. 261, 79-84
11.Verbraeken H.E., Hanssens M., Priem H., Lafaut B.A. and De Laey J.J. (1997). Ocular non-Hodgkin’s lymphoma: a clinical study of nine cases. Br. J. Ophthalmol. 81 (1), 31-36
12.Lafaut B.A., Mestdagh C., Kohno T., Gaudric A. and De Laey J.J. (1997). Indocyanine green angiography in choroidal osteoma. Graefes Arch. Clin. Exp. Ophthalmol. 235 (5), 330-337
13.Lafaut B.A. and De Laey J.J. (1996). Indocyanine green angiography in central serous chorioretinopathy. Bull. Soc. belge Ophthalmol. 262, 55-61
14.Lafaut B.A., Hanssens M., Verbraeken H. and De Laey J.J. (1996). Clinicopathologic correlation in a case of metastatic uveal tumor. Bull. Soc. belge Ophtalmol. 263, 27-37
15.Sallet G., Amoaku W.M., Lafaut B.A., Van Liefferinge B. and De Laey J.J. (1996). Indocyanine green angiography versus fluorescein angiography in the follow-up of choroidal melanomas treated with RU106/RH106. Bull. Soc. belge Ophtalmol. 263, 27-37
16.Lafaut B.A., De Vriese A.S. and Stulting A.A. (1997). Fundus fluorescein angiography of patients with severe hypertensive nephropathy. Graefes Arch. Clin. Exp. Ophthalmol. 235 (12), 749-754
17.Lafaut B.A., Priem H. and De Laey J.J. (1997). Indocyanine green angiography in angioid streaks. Bull. Soc. belge Ophtalmol. 265, 21-24
18.Salati C., Pantelis V., Lafaut B.A., Sallet G. and De Laey J.J. (1997). A 8 months indocyanine angiographic follow-up of a patient with serpiginous choroidopathy. Bull. Soc. belge Ophtalmol. 265, 29-33
19.Salati C., Lafaut B.A., Stevens A., De Laey J.J. and Kestelyn P. (1998). Indocyanine green angiography in a case of Bietti’s disease. Retina. 18 (1), 82-84
20.Lafaut B.A., Leys A.M., Scassellati-Sforzolini B., Priem H. and De Laey J.J. (1998). Comparison of fluorescein and indocyanine green angiography in angioid streaks. Graefes Arch. Clin. Exp. Ophthalmol. 236 (5), 346-353
21.Lafaut B.A., Salati C., Priem H. and De Laey J.J. (1998). Indocyanine green angiography is of value for the diagnosis of chronic central serous chorioretinopathy in elderly patients. Graefes Arch. Clin. Exp. Ophthalmol. 236 (7), 513-521
22.Verhaeghe I., Lafaut B.A., Brandt A., De Laey J.J. (1997). Retinal capillary hemangioma: von Hippel(-Lindau) disease. Bull. Soc. belge Ophtalmol. 267, 91-97
23.Meire F.M., Lafaut B.A., Speleman F. and Hanssens M. (1998). Isolated Norrie disease in a female caused by a balanced translocation t(X,6). Ophthalmic Genet. 19 (4), 203-207
24.Schelfhout V., Lafaut B., Van den Neste C., Kestelyn P. and De Laey J.J. (1998). Multiple evanescent white dot syndrome. Bull. Soc. belge Ophtalmol. 270, 19-23
25.Giovannini A., Scassellati-Sforzlini B., Lafaut B., Edeling J., D’Altobrando E. and De Laey J.J. (1999). Indocyanine green angiography of retinal pigment epithelial tears. Acta Ophthalmol. Scand. 77 (1), 83-87
26.De Meyer V., Lafaut B.A., Van de Sompel W. and De Laey J.J. (1999). Multifocal choroiditis with panuveitis and punctate inner choroidopathy: a mini review. Bull. Soc. belge Ophtalmol. 273, 115-124
27.Lafaut B.A., Meire F.M., Leys A.M., Dralands G. and De Laey J.J. (1999). Vasoproliferative retinal tumors associated with peripheral chorioretinal scars in presumed congenital toxoplasmosis. Graefes Arch. Clin. Exp. Ophthalmol. 237 (12), 1033-1038
28.Lafaut B.A., Bartz-Schmidt K.U., Vanden Broecke C., Aisenbrey S., De Laey J.J. and Heimann K. (2000). Clinicopathological correlation in exudative age-related macular degeneration: histological differentiation between classical and occult choroidal neovascularisation. Br. J. Ophthalmol. 84 (3), 239-243
29.Lafaut B.A., De Backer E., Kohno T., De Laey J.J. and Meire F.M. (2000). Indocyanine green angiography in Sorsby’s fundus dystrophy. Graefes Arch. Clin. Exp. Ophthalmol. 238 (2), 158-162
30.Thumann G., Aisenbrey S., Schaermeyer U., Lafaut B., Esser P., Walter P. and Bartz-Schmidt K.U. (2000). Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch. Ophthalmol. 118 (10), 1350-1355
31.Cursiefen C., Holbach L.M., Lafaut B., Heimann K., Kirchner T. and Naumann G.O. (2000). Oculocerebral non-Hodgkin’s lymphoma with uveal involvement: development of an epibulbar tumor after vitrectomy. Arch. Ophthalmol. 118 (10), 1437-1440
32.Lafaut B.A., Leys A.M., Snyers B., Rasquin F. and De Laey J.J. (2000). Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch. Clin. Exp. Ophthalmol. 238 (9), 752-759
33.Lafaut B.A., Aisenbrey S., Vanden Broecke C. and Bartz-Schmidt K.U. (2000). Clinicopathological correlation of deep retinal vascular anomalous complex in age-related macular degeneration. Br. J. Ophthalmol. 84 (11), 1269-1274
34.Lafaut B.A., Aisenbrey S., Vanden Broecke C., Bartz-Schmidt K.U. and Heimann K. (2000). Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina. 20 (6), 650-654
35.Szurman P., Di Tizio F.M., Lafaut B., Aisenbrey S., Grisanti S., Roters S. and Bartz-Schmidt K.U. (2000). Significance of postoperative face-down positioning after surgery for idiopathic macular holes: consecutive case-control study (German). Klin. Monatsbl. Augenheilkd. 217 (6), 351-355
36.Lafaut B.A., Aisenbrey S., Vanden Broecke C., Krott R., Jonescu-Cuypers C.P., Reynders S., Bartz-Schmidt K.U. (2001). Clinicopathological correlation of retinal pigment epithelial tears in exudative age-related macular degeneration: pretear, tear and scarred tear. Br. J. Ophthalmol. 85 (4), 454-460
37.Lafaut B.A., Aisenbrey S., Vanden Broecke C., Di Tizio F. and Bartz-Schmidt K.U. (2001). Clinicopathological correlation in exudative age-related macular degeneration: recurrent choroidal neovascularisation (review). Graefes Arch. Clin. Exp. Ophthalmol. 239 (1), 5-11
38.Lafaut B.A., Loeys B., Leroy B.P., Spileers W., De Laey J.J. and Kestelyn P. (2001). Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree. Graefes Arch. Clin. Exp. Ophthalmol. 239 (8), 575-582
39.Lafaut B.A. (2000). Clinicopathologic correlation of surgically removed submacular tissue. Bull. Soc. belge Ophtalmol. 278, 49-53
40.Aisenbrey S., Lafaut B., Szurman P., Grisanti S., Fricke J., Neugebauer A., Hilgers R.D., Esser P., Walter P. and Bartz-Schmidt K.U. (2002). Macular translocation with 360 degree retinotomy in the treatment if exudative macular degeneration. Functional and angiographic results (German). Der Ophthalmologe. 99 (3), 164-170
41.Aisenbrey S., Lafaut B.A., Szurman P., Grisanti S., Luke C., Krott R., Thumann G., Fricke J., Neugebauer A., Hilgers R.D., Esser P., Walter P. and Bartz-Scmidt K.U. (2002). Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch. Ophthalmol. 120 (4), 451-459
42.Lafaut B.A., Mietz H., Ortmann M. and Bartz-Schmidt K.U. (2002). Melanocytoma of the choroid: angiographic and histopathologic findings. Ophthalmic Surg. Lasers. 33 (2), 158-162
43.Reynders S., Lafaut B.A., Aisenbrey S., Vanden Broecke C., Lucke K., Walter P., Kirchhof B. and Bartz-Schmidt K.U. (2002). Clinicopathologic correlation in hemorrhagic age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 240 (4), 279-285
44.Kutchoukov B., Lafaut B. and De Laey J.J. (2002). Three-dimensional posterior segment ultrasonography: clinical experience. Bull. Soc. belge Ophtalmol. 283, 51-57
45.Aisenbrey S., Lafaut B.A., Reynders S., Szurman P., Grisanti S., Vanden Broecke C., Walter P. and Bartz-Schmidt K.U. (2003). Clinicopathological correlation of choroidal neovascularisation after external beam radiotherapy in age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 241 (4), 269-276
46.Hayami M., Decock C., Brabant P., Van Kerckhoven W., Lafaut B.A. and De Laey J.J. (2003). Optical coherence tomography of adult-onset vitelliform dystrophy. Bull. Soc. belge Ophtalmol. 289, 53-61
47.Grisanti S., Canbek S., Kaiserling E., Adam A., Lafaut B., Gelisken F., Szurman P., Henke-Fahle S., Oficjalska-Mlynczak J. and Bartz-Schmidt K.U. (2004). Expression of endoglin in choroidal neovascularisation. Exp. Eye Res. 78 (2), 207-213
48.Gelisken F., Lafaut B.A., Inhoffen W., Voelker M., Grisanti S. and Bartz-Schmidt K.U. (2004). Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy. Br. J. Ophthalmol. 88 (2), 207-213
49.Grisenti S., Tatar O., Canbek S., Lafaut B.A., Gelisken F., Inhoffen W., Szurman P., Aisenbrey S., Oficjalska-Mlynczak J., Bartz-Schmidt K.U. (2004). Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfin-photodynamic therapy. Am. J. Ophthalmol. 137 (5), 914-923
50.Yardley J., Leroy B.P., Hart-Holden N., Lafaut B.A., Loeys B., Messiaen L.M., Perveen R, Reddy M.A., Bhattacharya S.S., Traboulsi E., Baralle D., De Laey J.J., Puech B., Kestelyn P., Moore A.T., Manson F.D. and Black G.C. (2004). Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest. Ophthalmol. Vis. Sci. 45 (10), 3683-3689
LAMBERT Vincent
1.Lambert V., Munaut C., Jost M., Noel A., Werb Z., Foidart J.M. and Rakic J.M. (2002). Matrix metalloproteinase-9 contributes to choroidal neovascularisation. Am. J. Pathol. 161 (4), 1247-1253
2.Rakic J.M., Lambert V., Munaut C., Bajou K., Peyrollier K., Alvarez-Gonzalez M.L., Carmeliet P., Foidart J.M. and Noel A. (2003). Mice without uPA, tPA or plasminogen genes are resistant to experimental choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (4), 1732-1739
3.Rakic J.M., Lambert V., Deprez M., Foidart J.M., Noel A. and Munaut C. (2003). Estrogens reduce the expression of YKL-40 in the retina: implications for eye and joint diseases. Invest. Ophthalmol. Vis. Sci. 44 (4), 1740-1746
4.Lambert V., Munaut C., Carmeliet P., Gerard R.D., Declerck P.J., Gils A., Claes C., Foidart J.M., Noel A. and Rakic J.M. (2003). Dose-dependent modulation of choroidal neovascularisation by plasminogen activator inhibitor type I: implications for clinical trials. Invest. Ophthalmol. Vis. Sci. 44 (6), 2791-2797
5.Rakic J.M., Lambert V., Devy L., Luttun A., Carmeliet P., Claes C., Nguyen L., Foidart J.M., Noel A. and Munaut C. (2003). Invest. Ophthalmol. Vis. Sci. 44 (7), 3186-3193
6.Lambert V., Wielockx B., Munaut C., Galopin C., Jost M., Itoh T., Werb Z., Baker A., Libert C., Krell H.W., Foidart J.M., Noel A. and Rakic J.M. (2003). MMP-2 and MMP-9 synergize in promoting choroidal neovascularisation. FASEB J. 17 (15), 2290-2220
LEROY Bart
1.Messiaen L., Leroy B.P., De Bie S., De Pauw K., Van Roy N., Speleman F., Van Camp G. and De Paepe A. (1996). Refined genetic and physical mapping of BPES type II. Eur. J. Hum. Genet. 4 (1), 34-38
2.Leroy B.P., Carton D. and De Laey J.J. (1996). Ophthalmological signs of tuberous sclerosis. Bull. Soc. belge Ophtalmol. 262, 115-121
3.Uvijls A., Leroy B.P., Leys M., De Rouck A. and Kestelyn P. (1998). A large field panel D-15 test for low vision patients. Bull. Soc. belge Ophtalmol. 270, 57-65
4.Schocki M.M., Perrault I., Leroy B.P., Payne A.M., Dharmaraj S., Bhattacharya S.S., Kaplan J., Maumenee I.H., Koenekoop R., Meire F.M., Birch D.G., Heckenlively J.R. and Daiger S.P. (2000). Prevalence of AIPL1 mutations in inherited retinal degenerative disease. Mol. Genet. Metab. 70 (2), 142-150
5.Lehmann O.J., Ebenezer N.D., Jordan T., Fox M., Ocaka L., Payne A., Leroy B.P., Clark B.J., Hitchings R.A., Povey S., Khaw P.T. and Bhattacharya S.S. (2000). Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma. Am. J. Hum. Genet. 67 (5), 1129-1135
6.Khaliq S., Hameed A., Ismail M., Anwar K., Leroy B.P., Mehdi S.Q., Payne A.M. and Bhattacharya S.S. (2000). Novel locus for autosomal recessive cone-rod dystrophy CORD8 mapping to chromosome 1q12-q24
7.Payne A., Vithana E., Khaliq S., Hameed A., Deller J., Abu-Safieh L., Kermani S., Leroy B.P., Mehdi S.Q., Moore A.T., Bird A.C. and Bhattacharya S.S. (2000). RP1 protein truncating mutations predominate at the RP1 adRP locus. Invest. Ophthalmol. Vis. Sci. 41 (13), 4069-4073
8.Leroy B.P., Aragon-Martin J.A., Weston M.D., Bessant D.A., Willis C., Webster A.R., Bird A.C., Kimberling W.J., Payne A.M. and Bhattacharya S.S. (2001). Spectrum of mutations in USU2A in British patients with Usher syndrome type II. Exp. Eye Res. 72 (5), 503-509
9.De Baere E., Dixon M.J., Small K.W., Jabs E.W., Leroy B.P., Devriendt K., Gillerot Y., Mortier G., Meire F., Van Maldergem L., Courtens W., Hjalgrim H., Huang S., Liebaers I., Van Regemorter N., Touraine P., Praphanphoj V., Verloes A., Udar N., Yellore V., Chalukya M., Yelchits S., De Paepe A., Kuttenn F., Fellous M., Veitia R. and Messiaen L. (2001). Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum. Mol. Genet. 10 (15), 1591-1600
10.De Baere E., Beysen D., Oley C., Lorenz B., Cocquet J., De Sutter P., Devriendt K., Dixon M., Fellous M., Fryns J.P., Garza A., Jonsrud C., Koivisto P.A., Krause A., Leroy B.P., Meire F., Plomp A., Van Maldergem L., De Paepe A., Veitia R. and Messiaen L. (2003). FOXL2 and BPES: mutation hotspots, phenotypic variability and revision of the genotype-phenotype correlation. Am. J. Hum. Genet. 72 (2), 478-487
11.Blaydon D.C., Mueller R.F., Hutchin T.P., Leroy B.P., Bhattacharya S.S., Bird A.C., Malcolm S. and Bitner-Glindzicz M. (2003). The contribution of USH1C mutations and non-syndromic deafness in the UK. Clin. Genet. 63 (4), 303-307
12.Dharmaraj S., Leroy B.P., Sohocki M.M., Koenekoop R.K., Perrault I., Anwar K., Khaliq S., Devi R.S., Birch D.G., De Pool E., Izquierdo N., Van Maldergem L., Ismail M., Paine A.M., Holder G.E., Bhattacharya S.S., Bird A.C., Kaplan J., Maumenee I.H. (2004). The phenotype of Leber congenital amaurosis in patients with AIPL1 mutations. Arch. Ophthalmol. 122 (7), 1029-1037
13.Yardley J., Leroy B.P., Hart-Holden N., Lafaut B.A., Loeys B., Messiaen L.M., Perveen R., Reddy M.A., Bhattacharya S.S., Traboulsi E., Baralle D., De Laey J.J., Puech B., Kestelyn P., Moore A.T., Manson F.D. and Black G.C. (2004). Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest. Ophthalmol. Vis. Sci. 45 (10), 3683-3689
14.Leroy J.G., Leroy B.P., Emmery L.V., Messiaen L. and Spranger J.W. (2004). A new type of autosomal recessive spondyloepiphyseal dysplasia tarda. Am. J. Med. Genet. 125A (1), 49-56
15.Witters J.A., De Zaeytijd J., Leys M. and Leroy B.P. (2004). Progressive cone dystrophy and sensorineural hearing loss. Bull. Soc. belge Ophtalmol. 294, 35-42
BALI Ernesto
1.De Jong C., Bali E., Libert J. and Caspers-Velu L. (2000). ADCON-L hydrogel as a vitreous substitute: preliminary results. Bull. Soc. belge Ophtalmol. 278, 71-5
LEROY Bart
1.De Bleecker J.L., Leroy B.P. and Meire V.I. (2005). Reversible visual deficit and Corpus callosum lesions due to metronidazole toxicity. Eur. Neurol. 53 (2), 93-95
BALI Ernesto
1.Bali E., Huyghe P., Caspers L. and Libert J. (2003). Vitrectomy and silicone oil in the treatment of acute endophthalmitis. Bull. Soc. belge Ophtalmol. 288, 9-14
LEROY Bart
1.Beysen D., Raes J., Leroy B.P., Lucassen A., Yates J.R., Clayton-Smith J., Ilyina H., Brooks S.S., Christin-Maitre S., Fellous M., Fryns J.P., Kim J.R., Lapunzina P., Lemyre E., Meire F., Messiaen L.M., Oley C., Splitt M., Thomson J., Peer Y.V., Veitia R.A., De Paepe A. and De Baere E. (2005). Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am. J. Hum. Genet. 77 (2), 205-218
BALI Ernesto
1.Bali E., Willermain F., Caspers-Velu L., Dubois C., Dehou M.F., Velu T., Libert J. and Bruyns C. (2003). IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy. Int. J. Mol. Med. 12 (3), 305-310
MISSOTTEN Tom
1.Sifrim D., Holloway R.H., Tack J., Zelter A., Missotten T., Coulie B. and Janssens J. (1999). Effect of sumatriptan, a 5HT1 agonist, on the frequency of transient lower esophageal sphincter relaxations and gastroesophageal reflux in healthy subjects. Am. J. Gasteroenterol. 94 (11), 3158-3164
BOUSSERY Koen
1.Delaey C., Boussery K. and Van de Voorde J. (2000). A retinal-derived relaxing factor mediates the hypoxic vasodilation of retinal arteries. Invest. Ophthalmol. Vis. Sci. 41 (11), 3555-3560
2.Van de Voorde J., Boussery K. and Vanheel B. (2001). Role of the endothelium in the vasorelaxing effect of histamine on rat isolated gastric small arteries. Inflamm. Res. 50 (Suppl. 2), S120-121
MISSOTTEN Tom
1.Vanschoubroek K., Missotten T. and Dralands L. (2001). Pitfalls in the diagnosis of craniopharyngioma: 2 case reports. Bull. Soc. belge Ophtalmol. 281, 41-47
BOUSSERY Koen
1.Boussery K., Franki A.S., Delaey C. and Van de Voorde J. (2002). A vasorelaxing factor is released form mouse retinal tissue. Ophthalmic Res. 34 (3), 172-177
MISSOTTEN Tom
1.Bremond-Gignac D., Tixier J., Missotten T., Laroche L. and Beresniak A. (2002). Evaluation of the quality of life in ophthalmology (French) (review). Presse Med. 31 (34), 1607-1612
BOUSSERY Koen
1.Mitamura M., Boussery K., Horie S., Murayama T. and Van de Voorde J. (2002). Vasorelaxing effect of mesaconitine, an alkaloid from Aconitum japonicum, on rat small gastric artery: possible involvement of endothelium-derived hyperpolarizing factor. Jpn. J. Pharmacol. 89 (4), 380-387
MISSOTTEN Tom
1.Awotescu O., Missotten T., Pitcher M.C., Lynn W.A. and Lightman S. (2004). Uveitis in a patient receiving rifabutin for Crohn’s disease. J. R. Soc. Med. 97 (9), 440-441
BOUSSERY Koen
1.Boussery K., Delaey C. and Van de Voorde J. (2002). Rat retinal tissue releases a vasorelaxing factor. Invest. Ophthalmol. Vis. Sci. 43 (10), 3279-3286
MISSOTTEN Tom
1.Missotten T., Verhamme T., Blanckaert J. and Missotten G. (2004). Optical formula to predict outcomes after implantation of accommodating intraocular lenses. J. Cataract Refract. Surg. 30 (10), 2084-2087
BOUSSERY Koen
1.Delaey C., Boussery K. and Van de Voorde J. (2002). Contractility studies on isolated bovine choroidal small arteries: determination of the active and passive wall tension-internal circumference relation. Exp. Eye Res. 75 (3), 243-248
RAKIC Jean-Marie
1.Rakic J.M. (1993). Cyclosporin in ophthalmology. Bull. Soc. belge Ophtalmol. 247 (1), 67-70
BOUSSERY Koen
1.De Clerck I., Boussery K., Pannier J.L. and Van de Voorde J. (2003). Potassium potently relaxes small rat skeletal muscle arteries. Med. Sci. Sports Exerc. 35 (12), 2005-2012
RAKIC Jean-Marie
1.Rakic J.M., Galand A. and Vrensen G.F. (1997). Separation of fibres from the capsule enhances mitotic activity of human lens epithelium. Exp. Eye Res. 64 (1), 67-72
BOUSSERY Koen
1.Boussery K., Delaey C. and Van de Voorde J. (2004). Influence of adrenomedullin on tone of isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 45 (2), 552-559
RAKIC Jean-Marie
1.Wormstone I.M., Liu C.S., Rakic J.M., Marcantonio J.M., Vrensen G.F. and Duncan G. (1997). Human lens epithelial cell proliferation in a protein-free medium. Invest. Ophthalmol. Vis. Sci. 38 (2), 396-404
BOUSSERY Koen
1.De Clerck I., Boussery K., Pannier J.L. and Van de Voorde J. (2005). Hyperosmolarity increase K+-induced vasodilations in rat skeletal muscle arterioles. Med. Sci. Sports Exerc. 37 (2), 220-226
RAKIC Jean-Marie
1.Van Cauwenberge F., Rakic J.M. and Galand A. (1997). Complicated posterior capsulorhexis: aetiology, management and outcome. Br. J. Ophthalmol. 81 (3), 195-198
BOUSSERY Koen
1.Boussery K., Delaey C. and Van de Voorde J. (2005). The vasorelaxing effect of CGRP and natriuretic peptides in isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 46 (4), 1420-1427
RAKIC Jean-Marie
1.Massoud H., Comhaire-Poutchinian Y. and Rakic J.M. (1997). Transvitreal endocryoapplication of the ciliary body (French). Bull. Soc. belge Ophtalmol. 267, 177-181
BOUSSERY Koen
1.Boussery K., Lambrecht S., Delaey C. and Van de Voorde J. (2005). Clozapine directly relaxes bovine retinal arteries. Curr. Eye Res. 30 (2), 139-146
RAKIC Jean-Marie
1.Rakic J.M., Galand A. and Vrensen G.F. (2000). Lens epithelial cell proliferation in human posterior capsule opacification specimens. Exp. Eye Res. 71 (5), 489-494
BOUSSERY Koen
1.Peeters L., Sanders N.N., Braeckmans K., Boussery K., Van de Voorde J., De Smedt S.C. and Demeester J. (2005). Vitreous: a barrier to non-viral ocular gene therapy. Invest. Ophthalmol. Vis. Sci. 46 (10), 3553-3561
RAKIC Jean-Marie
1.Marcantonio J.M., Rakic J.M., Vrensen G.F. and Duncan G. (2000). Lens cell populations studied in human donor capsular bags with implanted intraocular lenses. Invest. Ophthalmol. Vis. Sci. 41 (5), 1130-1141
CABAY Laurence
1.Cabay J.E., Boverie J.H. and Dondelinger R.F. (1998). Percutaneous catheter drainage of external fistulas of the pancreatic ducts. Eur. Radiol. 8 (3), 445-8
RAKIC Jean-Marie
1.Lambert V., Munaut C., Noel A., Frankenne F., Bajou K., Gerard R., Carmeliet P., Defresne M.P., Foidart J.M. and Rakic J.M. (2001). Influence of plasminogen activator inhibitor type 1 on choroidal neovascularisation. FASEB J. 15 (6), 1021-1027
CABAY Laurence
1.Cabay L., Willermain F., Bruyns C., Verdebout J.M., Witta Y., Baffi J., Velu T., Libert J., Caspers-Velu L., Maho A. and Lespagnard L. (2003). CXCR4 expression in vitreoretinal membranes. Br. J. Ophthalmol. 87 (5), 567-569
RAKIC Jean-Marie
1.Munaut C., Lambert V., Noel A., Frankenne F., Deprez M., Foidart J.M. and Rakic J.M. (2001). Presence of oestrogen receptor type beta in human retina. Br. J. Ophthalmol. 85 (7), 877-882
CLAERHOUT Ilse
1.Claerhout I. and Kestelyn P. (1999). Acanthamoeba keratitis: a review. Bull. Soc. belge Ophtalmol. 274, 71-82
RAKIC Jean-Marie
1.Lambert V., Munaut C., Jost M., Noel A., Werb Z., Foidart J.M. and Rakic J.M. (2002). Matrix metalloproteinase-9 contributes to choroidal neovascularisation. Am. J. Pathol. 161 (4), 1247-1253
CLAERHOUT Ilse
1.Beele H., Claerhout I., Kestelyn P., Dierckxens L., Nayaert J.M. and De Laey J.J. (2001). Bilateral corneal melting in a patient with paraneoplastic pemphigus. Dermatol. 202 (2), 147-150
RAKIC Jean-Marie
1.Rakic J.M., Lambert V., Munaut C., Bajou K., Peyrollier K., Alvarez-Gonzalez M.L., Carmeliet P., Foidart J.M. and Noel A. (2003). Mice without uPA, tPA or plasminogen genes are resistant to experimental choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (4), 1732-1739
CLAERHOUT Ilse
1.Claerhout I., Beele H., Verstraete A., Van den Broecke C. and Kestelyn P. (2001). The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model. Graefes Arch. Clin. Exp. Ophthalmol. 239 (2), 152-157
RAKIC Jean-Marie
1.Rakic J.M., Lambert V., Deprez M., Foidart J.M., Noel A. and Munaut C. (2003). Estrogens reduce the expression of YKL-40 in the retina: implications for eye and joint diseases. Invest. Ophthalmol. Vis. Sci. 44 (4), 1740-1746
CLAERHOUT Ilse
1.Claerhout I., Beele H., Van den Abeele K. and Kestelyn P. (2002). Therapeutic penetrating keratoplasty: clinical outcome and evolution of endothelial cell denstity. Cornea. 21 (7), 637-642
RAKIC Jean-Marie
1.Rakic J.M., Maillard C., Jost M., Bajou K., Masson V., Devy L., Lambert V., Foidart J.M. and Noel A. (2003). Role of plasminogen activator-plasmin system in tumor angiogenesis (review). Cell. Mol. Life Sci. 60 (3), 463-473
CLAERHOUT Ilse
1.Boonstra F., Claerhout I., Hol F., Smit G., van Collenburg V. and Meire F. (2002). Corneal decompensation in a boy with Kearns-Sayre syndrome. Ophthalmic Genet. 87 (5), 247-251
RAKIC Jean-Marie
1.Lambert V., Munaut C., Carmeliet P., Gerard R.D., Declerck P.J., Gils A., Claes C., Foidart J.M., Noel A. and Rakic J.M. (2003). Dose-dependent modulation of choroidal neovascularisation by plasminogen activator inhibitor type I: implications for clinical trials. Invest. Ophthalmol. Vis. Sci. 44 (6), 2791-2797
CLAERHOUT Ilse
1.Sinnaeve B.A., Decaestecker T.N., Claerhout I.J., Kestelyn P., Remon J.P. and Van Bocxlaer J.F. (2003). Confirmation of ofloxacin precipitation in corneal deposits by microbore liquid chromatography-quadrupole time-of-flight tandem mass spectrometry. J. Chromatogr. B. Analyt. Biomed. Life Sci. 785 (1), 193-196
RAKIC Jean-Marie
1.Rakic J.M., Lambert V., Devy L., Luttun A., Carmeliet P., Claes C., Nguyen L., Foidart J.M., Noel A. and Munaut C. (2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (7), 3186-3193
CLAERHOUT Ilse
1.Claerhout I. (2003). Corneal opacification following keratoplasty in the rat model. Br. J. Ophthalmol. 87 (2), 249-250
RAKIC Jean-Marie
1.Rakic J.M., Zelinkova M., Comhaire-Poutchinian Y., Galand A. and Duchateau E. (2003). Treatment of Graves macular edema with intravitreal injection of corticosteroids (French). Bull. Soc. belge Ophtalmol. 288, 43-48
CLAERHOUT Ilse
1.Claerhout I., Kestelyn P., Meire F., Remon J.P., Decaestecker T. and Van Bocxlaer J. (2003). Corneal deposits after the topical use of ofloxacin in two children with vernal keratoconjunctivitis. Br. J. Ophthalmol. 87 (5), 646
2.Claerhout I., Beele H., De Bacquer D. and Kestelyn P. (2003). Factors influencing the decline in endothelial cell density after corneal allograft rejection. Invest. Ophthalmol. Vis. Sci. 44 (11), 4747-4752
RAKIC Jean-Marie
1.Lambert V., Wielockx B., Munaut C., Galopin C., Jost M., Itoh T., Werb Z., Baker A., Libert C., Krell H.W., Foidart J.M., Noel A. and Rakic J.M. (2003). MMP-2 and MMP-9 synergize in promoting choroidal neovascularisation. FASEB J. 17 (15), 2290-2292
CLAERHOUT Ilse
1.Goegebuer A., Ajay L., Claerhout I. and Kestelyn P. (2003). Results of penetrating keratoplasty in syphilitic interstitial keratitis. Bull. Soc. belge Ophtalmol. 290, 35-39
RAKIC Jean-Marie
1.Rakic J.M. and Hermans G. (2004). Patient access to the medical file (French). Bull. Soc. belge Ophtalmol. 291, 47-50
CLAERHOUT Ilse
1.Claerhout I., Kestelyn P., Debacker V., Beele H. and Leclercq G. (2004). Role of natural killer cells in the rejection process of corneal allografts in rats. Transplantation. 77 (5), 676-682
RAKIC Jean-Marie
1.Blaise P., Duchateau E., Duchesne B., Comhaire Y. and Rakic J.M. (2004). Retinal vascular occlusions: diagnosis and management (French). Rev. Med. Interne. 25 (12), 881-890
CLAERHOUT Ilse
1.Claerhout I., Goegebuer A., Van Den Broecke C. and Kestelyn P. (2004). Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch. Clin. Exp. Ophthalmol. 242 (8), 648-653
RAKIC Jean-Marie
1.Rakic J.M., Blaise P. and Foidart J.M. (2005). Pegaptanib and age-related macular degeneration. N. Engl. J. Med. 352 (16), 1720-1721
CLAERHOUT Ilse
1.Claerhout I. and Kestelyn P. (2004). Results of penetrating keratoplasty in syphilitic interstitial keratitis (French). Rev. belge Med. Dent. 59 (1), 34-42
RAKIC Jean-Marie
1.Xhauflaire G., Uhoda E. and Rakic J.M. (2005). Eye and ultraviolet light (French). Rev. Med. Liege. 60 Suppl. 1, 99-102
CLAES Catherine
1.De Graeve C., Van de Sompel W. and Claes C. (1999). Ocular ischemic syndrome: two case reports of bilateral involvement. Bull. Soc. belge Ophtalmol. 273, 69-74
RAKIC Jean-Marie
1.Blaise P., Comhaire Y. and Rakic J.M. (2005). Giant macular hole as an atypical consequence of a toxoplasmic chorioretinitis. Arch. Ophthalmol. 123 (6), 863-864
CLAES Catherine
1.Dorchy H., Claes C. and Verougstraete C. (2002). Risk Factors of Developing Proliferative Retinopathy in Type 1 Diabetic Patients: Role of BMI. Diabetes Care. 4, 798-799
RAKIC Jean-Marie
1.Blaise P., Duchateau E., Comhaire Y. and Rakic J.M. (2005). Improvement of visual acuity after photodynamic therapy for choroidal neovascularization in choroidal osteoma. Acta Ophthalmol. Scand. 83 (4), 515-516
CLAES Catherine
1.Lambert V., Munaut C., Carmeliet P., Gerard R.D., Declerck P.J., Gils A., Claes C., Foidart J.M., Noel A. and Rakic J.M. (2003). Dose-dependent modulation of choroidal neovascularisation by plasminogen activator inhibitor type I: implications for clinical trials. Invest. Ophthalmol. Vis. Sci. 44 (6), 2791-2797
RAKIC Jean-Marie
1.Barile S., Van Cauwenberge F. and Rakic J.M. (2005). Diabetic retinopathy (French). Rev. Med. Liege. 60 (5-6), 487-489
CLAES Catherine
1.Rakic J.M., Lambert V., Devy L., Luttun A., Carmeliet P., Claes C., Nguyen L., Foidart J.M., Noel A. and Munaut C. (2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (7), 3186-3193
ROBE-COLLIGNON Nathalie
1.Collignon-Brach J. and Robe-Collignon N. (2000). Non perforating trabecular surgery with reticulated hyaluronic acid implant (French). Bull. Soc. belge Ophtalmol. 276, 61-68
CLAES Catherine
1.Geerts L., Pertile G., Van de Sompel W., Moreels T. and Claes C. (2004). Vitrectomy for epiretinal membranes: visual outcome and prognostic criteria. Bull. Soc. belge Ophtalmol. 293, 7-15
ROBE-COLLIGNON Nathalie
1.Collignon-Brach J.D., Ravet O. and Robe-Collignon N. (2000). Surgical indications in coexisting cataracts and glaucoma (French) (review). Bull. Soc. belge Ophtalmol. Suppl. 11-36
CLAES Catherine
1.Demols P., Claes C.A., Farber C.M. and Rasquin F. (2004). Macular CMV retinitis: a case report. Bull. Soc. belge Ophtalmol. 293, 17-21
ROBE-COLLIGNON Nathalie
1.Robe-Collignon N.J. and Collignon-Brach J.D. (2000). Non perforating trabecular surgery with reticulated hyaluronic acid implant (French). Bull. Soc. belge Ophtalmol. Suppl. 45-54
COOLS Doris
1.Cools D., Debiec-Rychter M., Parys-Van Ginderdeuren R., Hagemeijer-Hausman A., Van den Oord J. and Spileers W. (2000). Preliminary results of the FRO project: chromosomal abnormalities in primary uveal melanoma. Bull. Soc. belge Ophtalmol. 278, 67-70
ROBE-COLLIGNON Nathalie
1.Banks M.C., Robe-Collignon N.J., Rizzo J.F. 3rd and Pasquale L.R. (2003). Scanning laser polarimetry of edematous and atrophic optic nerve heads. Arch. Ophthalmol. 121 (4), 484-490
DE BAERE Elvire
1.De Baere E., Speleman F., Van Roy N., De Paepe A. and Messiaen L. (1998). Assignment of the cellular retinol-binding protein 1 gene (RBP1) and of the coatomer beta subunit gene (COPB2) to human chromosome band 3q23 by in situhybridization. Cytogenet. Cell. Genet. 82 (3-4), 226-227
ROZEMA Jos
1.Rozema J.J., Van Dyck D.E.M. and Tassignon M.J. (2005). Clinical comparison of 5 aberrometers (I). Technical specifications. J. Cat. Refract. Surg. 31 (6), 1114-1127
DE BAERE Elvire
1.De Baere E., Speleman F., Van Roy N., De Paepe A. and Messiaen L. (1998). Assignment of SHOX2 (alias OG12X and SHOT) to human chromosome bands 3q25-q26.1 by in situ hybridization. Cytogenet. Cell. Genet. 82 (3-4), 228-229
ROZEMA Jos
1.Rozema J.J., Van Dyck D.E.M., Pauw M., Van Der Spek B. and Tassignon M.J. (submitted). Clinical comparison of 5 aberrometers (II). Statistical comparison on a test group. J. Cat. Refract. Surg.
DE BAERE Elvire
1.De Baere E., Van Roy N., Speleman F., Fukushima Y., De Paepe A. and Messiaen L. (1999). Closing in on the BPES gene on 3q2- mapping of a de novo reciprocal translocation t(3;4)(q23;p15.2) breakpoint within a 45-kb cosmid and mapping of three candidate genes, RBP1, RBP2 and beta’-COP, distal to the breakpoint. Genomics. 57 (1), 70-78
2.De Baere E., Fukushima Y., Small K., Udar N., Van Camp G., Verhoeven K., Palotie A., De Paepe A. and Messiaen L. (2000). Identification of BPESC1, a novel gene disrupted by a balanced chromosomal translocation, t(3;4)(q23;p15.2), in a patient with BPES. Genomics. 68 (3), 296-304
STALMANS Ingeborg
1.Vanderschueren A., Stalmans I., Lombaerts R. and Leys A. (1996). Ocular abnormalities in patients with Alport’s syndrome. Nephrol. Dial. Transplant. 11 (11), 2355-2358
DE BAERE Elvire
1.Gross C., De Baere E., Lo A., Chang W. and Messiaen L. (2001). Cloning and characterization of human WDR10, a novel gene located at 3q21 encoding a WD-repeat protein that is highly expressed in pituitary and testis. DNA Cell Biol. 20 (1), 41-52
STALMANS Ingeborg
1.Stalmans I., Buys K., Leys A. and Dralands L. (1997). Spontaneous evolution of stage I and II macular holes. Bull. Soc. belge Ophtalmol. 267, 37-42
DE BAERE Elvire
1.De Baere E., Dixon M.J., Small K.W., Jabs E.W., Leroy B.P., Devriendt K., Gillerot Y., Mortier G., Meire F., Van Maldergem L., Courtens W., Hjalgrim H., Huang S., Liebaers I., Van Regemorter N., Touraine P., Praphanphoj V., Verloes A., Udar N., Yellore V., Chalukya M., Yelchits S., De Paepe A., Kuttenn F., Fellous M., Veitia R. and Messiaen L. (2001). Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum. Molec. Genet. 10 (15), 1591-1600
2.De Baere E., Lemercier B., Christin-Maitre S., Durval D., Messiaen L., Fellous M. and Veitia R. (2002). FOXL2 mutation screening in a large panel of POF patients and XX males. J. Med. Genet. 39 (8), 43
STALMANS Ingeborg
1.Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I., Ehler E., Kakkar V.V., Stalmans I., Mattot V., Perriard J.C., Dewerchin M., Flameng W., Nagy A., Lupu F., Moons L., Collen D., D’Amore P.A. and Shima D.T. (1999). Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5 (5), 495-502
DE BAERE Elvire
1.Cocquet J., Pailhoux E., Jaubert F., Servel N., Xia X., Pannetier M., De Baere E., Messiaen L., Cotinot C., Fellous M. and Veitia R. (2002). Evolution and expression of FOXL2. J. Med. Genet. 39 (12), 916-921
STALMANS Ingeborg
1.Spiritus A., Dralands L., Stalmans P., Stalmans I. and Spileers W. (2000). OCT study of fellow eyes of macular holes. Bull. Soc. belge Ophtalmol. 275, 81-84
DE BAERE Elvire
1.De Baere E., Beysen D., Oley C., Lorenz B., Cocquet J., De Sutter P., Devriendt K., Dixon M., Fellous M., Fryns J.P., Garza A., Jonsrud C., Koivisto P.A., Krause A., Leroy B.P., Meire F., Plomp A., Van Maldergem L., De Paepe A., Veitia R. and Messiaen L. (2003). FOXL2 and BPES: mutational hotspots, phenotypic variability and revision of the genotype-phenotype correlation. Am. J. Hum. Genet. 72 (2), 478-487
STALMANS Ingeborg
1.Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., Di Palma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K.H., Foidart J.M., Schaper W., Charnock-Jones D.S., Hicklin D.J., Herbert J.M., Collen D. and Persico M.G. (2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7 (5), 575-583
DE BAERE Elvire
1.Cocquet J., De Baere E., Caburet S. and Veitia R. (2003). Compositional biases and polyalanine runs in humans. Genetics. 165 (3), 1613-1617
STALMANS Ingeborg
1.Stalmans I., Ng Y.S., Rohan R., Fruttiger M., Bouche A., Yuce A., Fujisawa H., Hermans B., Shani M., Jansen S., Hicklin D., Anderson D.J., Gardiner T., Hammes H.P., Moons L., Dewerchin M., Collen D., Carmeliet P. and D’Amora P.A. (2002). Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109 (3), 327-336
DE BAERE Elvire
1.Cocquet J., De Baere E., Gareil M., Pannetier M., Xia X., Fellous M. and Veitia R.A. (2003). Structure, evolution and expression of the FOXL2 transcription unit (review). Cytogenet. Genome Res. 101 (3-4), 206-211
STALMANS Ingeborg
1.Stalmans P., Van Aken E.H., Veckeneer M., Feron E.J. and Stalmans I. (2002). Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am. J. Ophthalmol. 134 (2), 282-285
DE BAERE Elvire
1.Beysen D., Vandesompele J., Messiaen L., De Paepe A. and De Baere E. (2004). The human FOXL2 mutation database. Hum. Mutat. 24 (3), 189-193
STALMANS Ingeborg
1.Stalmans I., Lambrechts D., De Smet F., Jansen S., Wang J., Maity S., Kneer P., von der Ohe M., Swillen A., Maes C., Gewillig M., Molin D.G., Hellings P., Boetel T., Haardt M., Compernolle V., Dewerchin M., Plaisance S., Vlietinck R., Emanuel B., Gittenberger-de Groot A.C., Scambler P., Morrow B., Driscol D.A., Moons L., Esguerra C.V., Carmeliet G., Behn-Krappa A., Devriendt K., Collen D., Conway S.J. and Carmeliet P. (2003). VEGF: a modifer of the del22q11 (DiGeorge) syndrome? Nat. Med. 9 (2), 173-182
DE BAERE Elvire
1.Caburet S., Demarez A., Moumne L., Fellous M., De Baere E. and Veitia R.A. (2004). A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation. J. Med. Genet. 41 (12), 932-936
STALMANS Ingeborg
1.Stalmans P., Van Aken E.H., Melles G., Veckeneer M., Feron E.J. and Stalmans I. (2003). Trypan blue not toxic for retinal pigment epithelium in vitro. Am. J. Ophthalmol. 135 (2), 234-236
DE BAERE Elvire
1.Beysen D., Raes J., Leroy B.P., Lucassen A., Yates J.R., Clayton-Smith J., Ilyina H., Brooks S.S., Christin-Maitre S., Fellous M., Fryns J.P., Kim J.R., Lapunzina P., Lemyre E., Meire F., Messiaen L.M., Oley C., Splitt M., Thomson J., Peer Y.V., Veitia R.A., De Paepe A. and De Baere E. (2005). Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharochimosis syndrome. Am. J. Hum. Genet. 77 (2), 205-218
STALMANS Ingeborg
1.Devriendt K., Swillen A., Stalmans I. and Casteels I. (2005). Pulmonary atresia/ventricular septal defect associated with facial port-wine stain and retinal vascular abnormality: a new constellation or deletion in chromosome 22q11.2? Am. J. Med. Genet. A. 132 (3), 340-341
DE JONG Casper
1.De Jong C., Bali E., Libert J. and Caspers-Velu L. (2000). ADCON-L hydrogel as a vitreous substitute: preliminary results. Bull. Soc. belge Ophtalmol. 278, 71-75
STALMANS Peter
1.Stalmans P. and Himpens B. (1997). Confocal imaging of Ca2+ signaling in cultured rat retinal pigment epithelial cells during mechanical and pharmacologic stimulation. Invest. Ophthalmol. Vis. Sci. 38 (1), 176-187
DE KEYZER Katrien
1.De Keyzer K. and Tassignon M.J. (2004). Case report: acute unilateral loss of visual acuity after a visit to the dentist: an unusual complication after the use of an anesthetic combined with adrenaline (French). Rev. belge Med. Dent. 59 (1), 30-33
STALMANS Peter
1.Stalmans P. and Himpens B. (1997). Effect of increasing glucose and protein phosphorylation on intercellular communication in cultured rat retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 38 (8), 1598-1609
DELAEY Christophe
1.Delaey C. and Van de Voorde J. (1995). Prostanoid-induced contractions are blocked by sulfonylureas. Eur. J. Pharmacol. 280 (2), 179-184
STALMANS Peter
1.Stalmans P., Leys A. and Van Limbergen E. (1997). External beam radiotherapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularisation in age-related macular degeneration: a review of 111 cases. Retina. 17 (6), 481-492
DELAEY Christophe
1.Delaey C. and Van de Voorde J. (1997). Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction. Eur. J. Pharmacol. 325 (1), 41-46
STALMANS Peter
1.Stalmans P. and Himpens B. (1998). A decreased Ca2+-wave propagation is found among cultured RPE cells from dystrophic RCS rats. Invest. Ophthalmol. Vis. Sci. 39 (8), 1493-1502
DELAEY Christophe
1.Van de Voorde J., Delaey C, Depypere H. and Vanheel B. (1998). Mechanisms involved in the vasorelaxing influence of histamine on isolated human subcutaneous resistance arteries. Eur. J. Pharmacol. 349 (1), 61-66
STALMANS Peter
1.D’Hollander F., Stalmans P., Van Libergen E. and Leys A. (1998). Retrospective study on the evolution of visual acuity after external beam radiotherapy (20 Gy, 2 Gy fractions) for subfoveal choroidal neovascular membranes in ARMD. Bull. Soc. belge Ophtalmol. 270, 27-34
DELAEY Christophe
1.Delaey C. and Van de Voorde J. (1998). The effect of NO donors on bovine retinal small arteries and posterior ciliary arteries. Invest. Ophthalmol. Vis. Sci. 39 (9), 1642-1646
STALMANS Peter
1.Himpens B., Stalmans P., Gomez P., Malfait M. and Vereecke J. (1999). Intra- and intercellular Ca2+ signaling in retinal pigment epithelial cells during mechanical stimulation. FASEB J. 13 Suppl., S63-68
DELAEY Christophe
1.Delaey C. and Van de Voorde J. (1998). Retinal arterial tone is controlled by a retinal-derived relaxing factor. Circ. Res. 83 (7), 714-720
STALMANS Peter
1.Stalmans P., Spileers W. and Dralands L. (1999). The use of optical coherence tomography in macular diseases. Bull. Soc. belge Ophtalmol. 272, 15-30
DELAEY Christophe
1.Van de Voorde J., Delaey C., Depypere H. and Vanheel B. (1999). Role of the endothelium in the vasorelaxing influence of histamine on isolated human subcutaneous resistance arteries. Inflamm. Res. 48 (Suppl. 1), S100-101
STALMANS Peter
1.Stalmans P., Weckhuysen B., Schoonheydt R., Leys A., Missotten L., Spileers W. and Dralands L. (1999). How to protect your eyes from solar retinopathy. Bull. Soc. belge Ophtalmol. 272, 93-100
DELAEY Christophe
1.Delaey C. and Van de Voorde J. (2000). Pressure-induced myogenic responses in isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 41 (7), 1871-1875
STALMANS Peter
1.Stalmans P. and Himpens B. (1999). Properties of intra- and intercellular Ca(2+)-wave propagation elicited by mechanical stimulation in cultured RPE cells. Cell Calcium. 25 (6), 391-399
DELAEY Christophe
1.Delaey C., Boussery K. and Van de Voorde J. (2000). A retinal-derived relaxing factor mediates the hypoxic vasodilation of retinal arteries. Invest. Ophthalmol. Vis. Sci. 41 (11), 3555-3560
STALMANS Peter
1.Spaide R.F., Leys A., Herrmann-Delemazure B., Stalmans P., Tittl M., Yannuzzi L.A., Burke K.M., Fisher Y.L., Freund K.B., Guyer D.R., Slakter J.S. and Sorenson J.A. (1999). Radiation-associated choroidal neovasculopathy. Ophthalmol. 106 (12), 2254-2260
DELAEY Christophe
1.Delaey C. and Van De Voorde J. (2000). Regulatory mechanisms in the retinal and choroidal circulation (review). Ophthalmic Res. 32 (6), 249-256
STALMANS Peter
1.Leys A., Stalmans P. and Blanckaert J. (2000). Sclerochoroidal calcification with choroidal neovascularisation. Arch. Ophthalmol. 118 (6), 854-857
DELAEY Christophe
1.Delaey C. (2001). Retinal tissue modulates retinal arterial tone through the release of a potent vasodilating factor. Verh. K. Acad. Geneeskd. Belg. 63 (4), 335-357
STALMANS Peter
1.Raus P., Stalmans P., Demeuter E., Spileers W. and Dralands L. (2001). Unusual retinal vasculitis in a patient with protein S deficiency and systemic toxoplasmosis: a case report. Bull. Soc. belge Ophtalmol. 279, 7-12
DELAEY Christophe
1.Boussery K., Franki A.S., Delaey C. and Van De Voorde J. (2002). A vasorelaxing factor is released from mouse retinal tissue. Ophthalmic Res. 34 (3), 172-177
STALMANS Peter
1.Stalmans P., Parys-Vanginderdeuren R., De Vos R. and Feron E.J. (2001). ICG staining of the inner limiting membrane facilitates its removal during surgery for macular holes and puckers. Bull. Soc. belge Ophtalmol. 281, 21-26
DELAEY Christophe
1.Boussery K., Delaey C. and Van De Voorde J. (2002). Rat retinal tissue releases a vasorelaxing factor. Invest. Ophthalmol. Vis. Sci. 43 (10), 3279-3286
STALMANS Peter
1.Feron E.J., Veckeneer M., Parys-Van Ginderdeuren R., Van Lommel A., Melles G.R. and Stalmans P. (2002). Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch. Ophthalmol. 120 (2), 141-144
DELAEY Christophe
1.Delaey C., Boussery K. and Van de Voorde J. (2002). Contractility studies on isolated bovine choroidal small arteries: determination of the active and passive wall tension-internal circumference relation. Exp. Eye Res. 75 (3), 243-248
STALMANS Peter
1.Stalmans P., Van Aken E.H., Veckeneer M., Feron E.J. and Stalmans I. (2002). Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am. J. Ophthalmol. 134 (2), 282-285
DELAEY Christophe
1.Boussery K., Delaey C. and Van de Voorde J. (2004). Influence of adrenomedullin on tone of isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 45 (2), 552-559
STALMANS Peter
1.Stalmans P., Van Aken E.H., Melles G., Veckeneer M., Feron E.J. and Stalmans I. (2003). Trypan blue not toxic for retinal pigment epithelium in vitro. Am. J. Ophthalmol. 135 (2), 234-236
DELAEY Christophe
1.Boussery K., Delaey C. and Van de Voorde J. (2005). The vasorelaxing effect of CGRP and natriuretic peptides in isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 46 (4), 1420-1427
STALMANS Peter
1.Stalmans P., Feron E.J., Parys-Van Ginderdeuren R., Van Lommel A., Melles G.R. and Veckeneer M. (2003). Double vital staining using trypan blue and infracyanine green in macular pucker surgery. Br. J. Ophthalmol. 87 (6), 713-716
DELAEY Christophe
1.Boussery K., Lambrecht S., Delaey C. and Van de Voorde J. (2005). Clozapine directly relaxes bovine retinal arteries. Curr. Eye Res. 30 (2), 139-146
STALMANS Peter
1.Van de Moere A. and Stalmans P. (2003). Anatomical and visual outcome of macular hole surgery with infracyanine green-assisted peeling of the internal limiting membrane, endodrainage and silicone oil tamponade. Am. J. Ophthalmol. 136 (5), 879-887
DENYS Katrien
1.Vanduffel W., Fize D., Peuskens H., Denys K., Sunaert S., Todd J.T. and Orban G.A. (2002). Extracting 3D from motion: differences in human and monkey intraparietal cortex. Science. 298 (5592), 413-415
STALMANS Peter
1.Stalmans P., Van Lommel A. and Parys-Van Ginderdeuren R. (2003). Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathological correlation. Am. J. Ophthalmol. 136 (5), 961-962
DENYS Katrien
1.Fize D., Vanduffel W., Nelissen K., Denys K., Chef d’Hotel C., Faugeras O. and Orban G.A. (2003). The retinotopic organization of primate dorsal V4 and surrounding areas: a functional magnetic resonance imaging study in awake monkeys. J. Neurosci. 23 (19), 7395-7406
STALMANS Peter
1.Teba F.A., Mohr A., Eckardt C., Wong D., Kusaka S., Joondeph B.C., Feron E.J., Stalmans P., Van Overdam K. and Melles G.R. (2003). Trypan blue staining in vitreoretinal surgery. Ophthalmol. 110 (12), 2409-2412
DENYS Katrien
1.Orban G.A., Fize D., Peuskens H., Denys K., Nelissen K., Sunaert S., Todd J. and Vanduffel W. (2003). Similarities and differences in motion processing between the human and macaque brain: evidence from fMRI. Neuropsychologia 41 (13), 1757-1768
STALMANS Peter
1.van Meurs J.C., ter Averst E., Hofland L.J., van Hagen P.M., Mooy C.M., Baarsma G.S., Kuijpers R.W., Boks T. and Stalmans P. (2004). Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br. J. Ophthalmol. 88 (1), 110-113
DENYS Katrien
1.Denys K., Vanduffel W., Fize D., Nelissen K., Peuskens H., Van Essen D. and Orban G.A. (2004). The processing of visual shape in the cerebral cortex of human and non-human primates: a functional magnetic resonance imaging study. J. Neurosci. 24 (10), 2551-2565
STALMANS Peter
1.Kolacny D., Parys-Vanginderdeuren R., Van Lommel A. and Stalmans P. (2005). Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema. Bull. Soc. belge Ophtalmol. 296, 15-23
DENYS Katrien
1.Denys K., Vanduffel W., Fize D., Nelissen K., Sawamura H., Georgieva S., Vogels R., Van Essen D. and Orban G.A. (2004). Visual activation in prefrontal cortex is stronger in monkeys than in humans. J. Cogn. Neurosci. 16 (9), 1505-1516
STANESCU Dinu
1.De Potter P., Stanescu D., Caspers-Velu L. and Hofmans A. (2000). Photo essay: combined hamartoma of the retina and retinal pigment epithelium in Gorlin syndrome. Arch. Ophthalmol. 118 (7), 1004-1005
DILLEN Kathleen
1.Dillen K., Vandervoort J., Van den Mooter G., Verheyden L. and Ludwig A. (2004). Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int. J. Pharm. 275 (1-2), 171-187
STANESCU Dinu
1.Stanescu D., Bodaghi B., Huong du L.T., Milea D., Goulet-Salmon B., Piette J.C., Le Hoang P. (2003). Pseudotumor cerebri associated with Sjogren’s syndrome. Graefes Arch. Clin. Exp. Ophthalmol. 241 (4), 339-342
DILLEN Kathleen
1.Dillen K., Weyenberg W., Vandervoort J. and Ludwig A. (2004). The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. Eur. J. Pharm. Biopharm. 58 (3), 539-549
STANESCU Dinu
1.Buono L.M., Foroozan R., Savino P.J., Danesh-Meyer H.V. and Stanescu D. (2003). Posterior ischemic optic neuropathy after hemodialysis. Ophthalmol. 110 (6), 1216-1218
DILLEN Kathleen
1.Dillen K., Vandervoort J. and Ludwig A. (2005). Factorial design, physicochemical characterisation and activity of ciprofloxacin-loaded PLGA nanoparticles for ocular use. J. Control Release 101 (1-3), 369-371
STANESCU Dinu
1.Coscas F., Stanescu D., Coscas G. and Soubrane G. (2003). Feeder vessel treatment of choroidal neovascularisation in age-related macular degeneration (French). J. Fr. Ophthalmol. 26 (6), 602-608
DILLEN Kathleen
1.Bozdag S., Dillen K., Vandervoort J. and Ludwig A. (2005). The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles. J. Pharm. Pharmacol. 57 (6), 699-707
STANESCU Dinu
1.Stanescu D., Wattenberg S. and Cohen S.Y. (2003). Photodynamic therapy for choroidal neovascularisation secondary to choroidal nervus. Am. J. Ophthalmol. 136 (3), 575-576
DUCHESNE Bernard
1.Comhaire-Poutchinian Y., Duchesne B. and Ries M. (1993). The value of MRI in a difficult diagnosis of melanoma of the choroid (French). Bull. Soc. belge Ophtalmol. 248, 47-51
STANESCU Dinu
1.Tran T.H., Stanescu D., Caspers-Velu L., Rozenberg F., Liesnard C., Gaudric A., Le Hoang P. and Bodaghi B. (2004). Clinical characteristics of acute HSV-2 retinal necrosis (review). Am. J. Ophthalmol. 137 (5), 872-879
DUCHESNE Bernard
1.Marechal-Courtois C. and Duchesne B. (1993). Recurrent corneal erosion (French). Bull. Soc. belge Ophtalmol. 247 (1), 13-15
STANESCU Dinu
1.Grimm C., Wenzel A., Stanescu D., Samardzija M., Hotop S., Groszer M., Naash M., Gassmann M. and Reme C. (2004). Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J. Neurosci. 24 (25), 5651-5658
DUCHESNE Bernard
1.Duchesne B. (1993). HLA typing and corneal grafts (French). Bull. Soc. belge Ophtalmol. 247 (1), 29-32
STANESCU Dinu
1.Stanescu D. and Veriter C. (2005). A normal FEV1/VC ratio does not exclude airway obstruction. Respiration. 71 (4), 348-352
DUCHESNE Bernard
1.Duchesne B., Marechal-Courtois C. and Melin P. (1994). A case of keratitis due to Mycobacterium chelonae (French) (review). Bull. Soc. belge Ophtalmol. 254, 59-62
STANESCU Dinu
1.Diculescu M., Ciocarlan M., Ciocarlan M., Stanescu D., Ciprut T. and Marinescu T. (2005). Predictive factors for pseudocysts and peripancreatic collections in acute pancreatitis. Rom. J. Gastroenterol. 14 (2), 129-134
DUCHESNE Bernard
1.Locht B., Janssens M., Duchesne B. and Bonnet S. (1995). Normovolemic hemodilution in central retinal vein thrombosis: personal experience apropos of 14 cases (French). Bull. Soc. belge Ophthalmol. 259, 89-92
STANESCU Dinu
1.Stanescu D. and Pieters T. (2005). Anorexia nervosa and emphysema. Am. J. Respir. Crit. Care Med. 172 (3), 398-399
DUCHESNE Bernard
1.Comhaire-Poutchinian Y., Duchesne B., Collignon J., Ries M. (1996). Magnetic resonance imaging in the diagnosis of doubtful cases of small melanoma of the choroid (French). J. Fr. Ophtalmol. 19 (2), 111-119
VAN AKEN Elisabeth
1.De Bleecker J.L., Meire V.I., Declercq W. and Van Aken E. (1999). Immunolocalisation of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. Neuromuscul. Disord. 9 (4), 239-246
DUCHESNE Bernard
1.Joachim M., Andris C., Duchesne B. (1996). Pharma-clinics. How I treat … thyroid ophthalmopathy (French). Rev. Med. Liège. 51 (7), 449-452
VAN AKEN Elisabeth
1.Van Hoorde L., Van Aken E. and Mareel M. (2000). Collagen type I: a substrate and a signal for invasion (review). Prog. Mol. Subcell. Biol. 25, 105-134
DUCHESNE Bernard
1.Tahi H., Kondo H., Duchesne B., Lee W., Feuer W. and Parel J.M. (1998). Gel injection adjustable keratoplasty (GIAK): keratometric evaluation on cadaver eyes (French). Bull. Soc. belge Ophtalmol. 268, 13-17
VAN AKEN Elisabeth
1.Van Aken E., Papeleu P., De Potter P., De Laey J.J. and Mareel M. (2000). Cadherin expression in the eye (review). Bull. Soc. belge Ophtalmol. 278, 55-59
DUCHESNE Bernard
1.Duchesne B., Tahi H., Gautier S., Jallet V., Villain F., Parel J.M. (1998). Implantation of controlled-release 5-FU for the prevention of secondary cataract: preliminary study (French). Bull. Soc. belge Ophtalmol. 268, 69-72
VAN AKEN Elisabeth
1.Van Aken E., De Wever O., Correia da Rocha A.S. and Mareel M. (2001). Defective E-cadherin/catenin complexes in human cancer (review). Virchows Arch. 439 (6), 725-751
DUCHESNE Bernard
1.Duchesne B., Mans B., Lavalley B., Gerard C., Marechal-Courtois C., Betz P. and Tseng S.C. (1998). Use of the cryopreserved human amniotic membrane for reconstruction of the ocular surface (French). Bull. Soc. belge Ophtalmol. 268, 73-77
VAN AKEN Elisabeth
1.Van Aken E., Papeleu P., De Potter P., Bruyneel E., Philippe J., Seregard S., Kvanta A., De Laey J.J. and Mareel M.M. (2002). Structure and function of the N-cadherin/catenin complex in retinoblastoma. Invest. Ophthalmol. Vis. Sci. 43 (3), 595-602
DUCHESNE Bernard
1.Claes E., Duchesne B., Lavalleye B., Lejeune T., Delcourt J.C., Bouillenne C. and Marechal-Courtois C. (1998). Types of corneal transplantation: experience and review (French). Bull. Soc. belge Ophtalmol. 268, 87-92
VAN AKEN Elisabeth
1.Stalmans P., Van Aken E., Veckeneer M., Feron E.J. and Stalmans I. (2002). Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am. J. Ophthalmol. 134 (2), 282-285
DUCHESNE Bernard
1.Tahi H., Duchesne B., Parel J.M., Nose I., Denham D., Villain F. and Lacombe E. (1998). Keratoprosthesis by posterior fixation and mechanical biocompatibility: determination of intraocular pressure provoking aqueous humor leak and/or extrusion (French). Bull. Soc. belge Ophtalmol. 268, 87-92
VAN AKEN Elisabeth
1.Rodrigues S., Van Aken E., Van Bocxlaer S., Attoub S., Nguyen Q.D., Bruyneel E., Westley B.R., May F.M., Thim L., Mareel M., Gespach C. and Emami S. (2003). Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J. 17 (1), 7-16
DUCHESNE Bernard
1.Carrette S., Marechal-Courtois C., Hernandez J., Hayette M.P., Deprez M. and Duchesne B. (2000). Report of a case of Acanthamoeba keratitis (French). Bull. Soc. belge Ophtalmol. 275, 49-53
VAN AKEN Elisabeth
1.Van Aken E.H., De Wever O., Van Hoorde L., Bruyneel E., De Laey J.J. and Mareel M.M. (2003). Invasion of retinal pigment epithelial cells: N-cadherin, hepatocyte growth factor and focal adhesion kinase. Invest. Ophthalmol. Vis. Sci. 44 (2), 463-472
DUCHESNE Bernard
1.Duchesne B., Tahi H. and Galand A. (2001). Use of human fibrin glue and amniotic membrane transplant in corneal perforation. Cornea. 20 (2), 230-232
VAN AKEN Elisabeth
1.Stalmans P., Van Aken E.H., Melles G., Veckeneer M., Feron E.J. and Stalmans I. (2003). Trypan blue not toxic for retinal pigment epithelium in vitro. Am. J. Ophthalmol. 135 (2), 234-236
DUCHESNE Bernard
1.Hamaoui M., Tahi H., Chapon P., Duchesne B., Fantes F., Feuer W. and Parel J.M. (2001). Corneal preparation of eye bank eyes for experimental surgery. Cornea. 20 (3), 317-320
VAN TENTEN Yasmine
1.Tassignon M.J., De Groot V., Vervecken F. and Van Tenten Y. (1998). Secondary closure of posterior continuous curvilinear capsulorhexis in normal eyes and eyes at risk for postoperative inflammation. J. Cataract Refract. Surg. 24 (10), 1333-1338
DUCHESNE Bernard
1.Hick S., Duchesne B., Kaye O., Marechal-Courtois C. and Galand A. (2002). Corneal ulcers associated with rheumatoid arthritis (French). Rev. Med. Liège. 57 (4), 228-232
VAN TENTEN Yasmine
1.Van Tenten Y., De Wolf A., Willekens B., Vrensen G.F. and Tassignon M.J. (1999). Temperature threshold for cell death of lens epithelial cells in a human capsular bag model. Exp. Eye Res. 69 (5), 569-574
DUCHESNE Bernard
1.Barile P., Leroy C., Bolle S., Arrese J.E., Hermanns-Le T., Pierard G.E. and Duchesne B. (2004). Merkel cell carcinoma (French). J. Fr. Ophtalmol. 27 (4), 432-436
VAN TENTEN Yasmine
1.Van Tenten Y., De Groot V., Wuyts F.L. and Tassignon M.J. (2000). Quantitative measurement of the PCCC area in the postoperative period. Br. J. Ophthalmol. 84 (10), 1117-1120
DUCHESNE Bernard
1.Blaise P., Duchateau E., Duchesne B., Comhaire Y. and Rakic J.M. (2004). Retinal vascular occlusions: diagnosis and management (French). Rev. Med. Interne. 25 (12), 881-890
VAN TENTEN Yasmine
1.Van Tenten Y., Schuitmaker H.J., De Groot V., Willekens B., Vrensen G.F. and Tassignon M.J. (2000). Cell biological mechanisms underlying posterior capsule opacification: search for a therapy. Bull. Soc. belge. 278, 61-66
DUCHESNE Bernard
1.Hick S., Demers P.E., Brunette I., La C., Mabon M. and Duchesne B. (2005). Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea. 24 (4), 369-377
VAN TENTEN Yasmine
1.Van Tenten Y., Schuitmaker H.J., De Wolf A., Willekens B., Vrensen G.F. and Tassignon M.J. (2001). The effect of photodynamic therapy with bacteriochlorin A on lens epithelial cells in a capsular bag model. Exp. Eye Res. 72 (1), 41-48
FOLLENS Ingrid
1.Van Overmeire B., Follens I., Hartmann S., Creten W.L. and Van Acker K.J. (1997). Treatment of patent ductus arteriosus with ibuprofen. Arch. Dis. Child Fetal Neonatal Ed. 76 (3), F179-184
VAN TENTEN Yasmine
1.Van Tenten Y., Schuitmaker H.J., De Groot V., Willekens B., Vrensen G.F. and Tassignon M.J. (2002). A preliminary study on the prevention of posterior capsule opacification by photodynamic therapy with bacteriochlorin A in rabbits. Ophthalmic Res. 34 (3), 113-118
FOLLENS Ingrid
1.Follens I., Godts D., Evens P.A. and Tassignon M.J. (2001). Combined fourth and sixth cranial nerve palsy after lumbar puncture: a rare complication. A case report. Bull. Soc. belge Ophtalmol. 281, 29-33
VAN TENTEN Yasmine
1.De Groot V., Vrensen G.F., Willekens B., Van Tenten Y. and Tassignon M.J. (2003). In vitro study on the closure of posterior capsulorrhexis in the human eye. Invest. Ophthalmol. Vis. Sci. 44 (5), 2076-2083
FOLLENS Ingrid
1.Van Kerckhoven W., Lafaut B., Follens I. and De Laey J.J. (2001). Features of age-related macular degeneration on optical coherence tomography. Bull. Soc. belge Ophtalmol. 281, 75-84
WEYENBERG Wim
1.Weyenberg W. and Ludwig A. (2002). In vitro assessment of the interaction mechanisms between mucin and a cationic cellulosic derivative by rheological methods using an experimental design. Pharmazie. 57 (9), 628-631
2.Weyenberg W., Vermeire A., Remon J.P. and Ludwig A. (2003). Characterization and in vivo evaluation of ocular bioadhesive minitablets compressed at different forces. J. Control Release. 89 (2), 329-340
3.Hornof M., Weyenberg W., Ludwig A. and Bernkop-Schnurch A. (2003). Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. J. Control Release. 89 (3), 419-428
4.Weyenberg W., Todorov V. and Ludwig A. (2004). Rheological evaluation of the influence of sterilisation on ocular gels using an experimental design. Pharmazie. 59 (2), 121-125
5.Weyenberg W., Vermeire A., D’Haese E., Vanhaelewyn G., Kestelyn P., Callens F., Nelis H.J., Remon J.P. and Ludwig A. (2004). Effect of different sterilisation methods on the properties of bioadhesive powders and ocular minitablets, and clinical evaluation. Eur. J. Pharm. Sci. 23 (1), 77-87
6.Weyenbergh W., Vermeire A., Dhondt M.M., Adriaens E., Kestelyn P., Remon J.P. and Ludwig A. (2004). Ocular bioerodible minitablets as strategy for the management of microbial keratitis. Invest. Ophthalmol. Vis. Sci. 45 (9), 3229-3233
7.Dillen K., Weyenberg W., Vandervoort J. and Ludwig A. (2004). The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. Eur. J. Pharm. Biopharm. 58 (3), 539-549
8.Weyenberg W., Vermeire A., Vandervoort J., Remon J.P. and Ludwig A. (2005). Effects of roller compaction settings on the preparation of bioadhesive granules and ocular minitablets. Eur. J. Pharm. Biopharm. 59 (3), 527-536
9.Weyenberg W., Vermeire A., Remon J.P. and Ludwig A. (2005). Development and evaluation of sustained release ocular minitablets. J. Control Release. 101 (1-3), 371-374
10.Bozdag S., Weyenberg W. and Ludwig A. (2005). Rheological evaluation of dispersions, prepared with different non- and gamma-irradiated bioadhesive cospray dried powder mixtures. Pharmazie. 60 (8), 593-597
WILLERMAIN François
1.Willermain F., Caspers-Velu L., Baudson N., Dubois C., Hamdane M., Willems F., Velu T. and Bruyns C. (2000). Role and expression of CD40 on human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 41 (11), 3485-3491
2.Willermain F., Caspers-Velu L., Nowak B., Stordeur P., Mosselmans R., Salmon I., Velu T. and Bruyns C. (2002). Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eye. Br. J. Ophthalmol. 86 (12), 1417-1421
3.Willermain F., Greiner K. and Forrester J.V. (2002). Intensive immunosuppression treatment for central retinal vein occlusion in a young adult: a case report. Ocul. Immunol. Inflamm. 10 (2), 141-145
4.Cabay L., Willermain F., Bruyns C., Verdebout J.M., Witta Y., Baffi J., Velu T., Libert J., Caspers-Velu L., Maho A., Lespagnard L. (2003). CXCR4 expression in vitreoretinal membranes. Br. J. Ophthalmol. 87 (5), 567-569
5.Bali E., Willermain F., Caspers-Velu L., Dubois C., Dehou M.F., Velu T., Libert J. and Bruyns C. (2003). IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy. Int. J. Mol. Med. 12 (3), 305-310
6.Willermain F., Greiner K. and Forrester J.V. (2003). Atypical end-stage birdshot retinochoroidopathy. Ocul. Immunol. Inflamm. 11 (4), 305-307
7.Greiner K., Murphy C.C., Willermain F., Duncan L., Plskova J., Hale G., Isaacs J.D. and Dick A.D. (2004). Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation. Invest. Ophthalmol. Vis. Sci. 45 (1), 170-176